Omid Mohammad Tavakoli Rouzbehani

Mr. Omid Mohammad Tavakoli Rouzbehani

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2020 in Nutrition & Metabolism
Verified
Journal Article
Open access
PDF file
HJHamed Jafari
Hamed Jafari
PVParisa Varshosaz
Parisa Varshosaz
FHFatemeh Hajizadeh-Sharafabad
Fatemeh Hajizadeh-Sharafabad
HRHamid Reza Razmi
Hamid Reza Razmi
MAMahdi Amirpour
Mahdi Amirpour
VMVahid Maleki
Vahid Maleki
Diabetes mellitus is one of the most important threats to human health in the twenty-first century. The use of complementary and alternative medicine to prevent, control, and reduce the complications of diabetes mellitus is increasing at present. Glutamine amino acid is known as a functional food. The purpose of this systematic review is to determine the potential role of glutamine supplementation on metabolic variables in diabetes mellitus. For this review, PubMed, SCOPUS, Embase, ProQuest, and Google Scholar databases were searched from inception through April 2020. All clinical trial and animal studies assessing the effects of glutamine on diabetes mellitus were eligible for inclusion. 19 studies of 1482 articles met the inclusion criteria. Of the 19 studies, nine studies reported a significant increase in serum GLP-1 levels. Also, eight studies showed reducing in serum levels of fasting blood sugar, four studies reducing in postprandial blood sugar, and triglyceride after glutamine supplementation. Although glutamine resulted in a significant increase in insulin production in seven studies, the findings on Hb-A1c levels were inconclusive. In addition to, despite of the results was promising for the effects of glutamine on weight changes, oxidative stress, and inflammation, more precise clinical trials are needed to obtain more accurate results. In conclusion, glutamine supplementation could improve glycemic control and levels of incretins (such as GLP-1 and GIP) in diabetes mellitus. However, more studies are needed for future studies.

20 January 2021 in British Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
AFAmir Hossein Faghfouri
Amir Hossein Faghfouri
BBBehzad Baradaran
Behzad Baradaran
AKAlireza Khabbazi
Alireza Khabbazi
YBYaser Khaje Bishak
Yaser Khaje Bishak
MZMeysam Zarezadeh
Meysam Zarezadeh
BABeitullah Alipour
Beitullah Alipour
Chronic inflammation has been considered as the main cause of chronic diseases. Zn has anti-inflammatory effects by decreasing the expression of inflammatory markers. The present systematic review and meta-analysis study aims to evaluate the impact of Zn supplementation on inflammation. PubMed (Medline), Scopus, Web of Science, and Embase databases were searched up to 10 December 2020. Controlled trials which have investigated the effects of Zn supplementation on serum/plasma levels of inflammatory cytokines in subjects aged >15 years were included. A pooled meta-analysis was performed using a random effect model. Sensitivity analysis was performed to determine the robustness of the observed effect sizes. A total of twelve studies was included in meta-analysis. Zn could decrease IL-6 levels (standardised mean difference (SMD) = −0·76 pg/ml; 95 % CI −1·28, −0·24;P= 0·004). There was no significant change in TNF-α (SMD = 0·42 pg/ml; 95 % CI −0·31, 1·16;P= 0·257) and IL-2 levels (SMD = 1·64 pg/ml; 95 % CI −1·31, 4·59;P= 0·277) following Zn supplementation. However, Zn could increase IL-2 significantly after the deletion of one arm in sensitivity analysis (SMD = 2·96 pg/ml; 95 % CI 2·03, 3·88;P< 0·05). Conclusively, Zn supplementation can decrease the IL-6 level. Zn increased IL-2 level after the sensitivity analysis. Zn supplementation has not ameliorative effects on TNF-α.

13 April 2021 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
OROmid Mohammad Tavakoli Rouzbehani
Omid Mohammad Tavakoli Rouzbehani
MAMohsen Abbasnezhad
Mohsen Abbasnezhad
SKSorayya Kheirouri
Sorayya Kheirouri
MAMohammed Alizadeh
Mohammed Alizadeh

24 July 2022 in Phytotherapy Research
Verified
Journal Article
Closed access
OROmid Mohammad Tavakoli Rouzbehani
Omid Mohammad Tavakoli Rouzbehani
MAMohsen Abbasnezhad
Mohsen Abbasnezhad
SKSorayya Kheirouri
Sorayya Kheirouri
MAMohammad Alizadeh
Mohammad Alizadeh

25 November 2021 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
OROmid Mohammad Tavakoli Rouzbehani
Omid Mohammad Tavakoli Rouzbehani
AFAmir Hossein Faghfouri
Amir Hossein Faghfouri
MAMaryam Anbari
Maryam Anbari
ONOmid Nikpayam
Omid Nikpayam
HOHadi PourMirzaei Olyaei
Hadi PourMirzaei Olyaei
MAMohammed Alizadeh
Mohammed Alizadeh

1 September 2020 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
ONOmid Nikpayam
Omid Nikpayam
AFAmir Hossein Faghfouri
Amir Hossein Faghfouri
OROmid Mohammad Tavakoli Rouzbehani
Omid Mohammad Tavakoli Rouzbehani
SJSeyyed-Mostafa Jalali
Seyyed-Mostafa Jalali
MNMarziyeh Najafi
Marziyeh Najafi
GSGolbon Sohrab
Golbon Sohrab